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Introduction
Pharmacovigilance systems missions are to ensure medi-
cine safety through efficient and timely collection,
assessment, and communication of risks and benefits to
support decision making at various levels of the health
care system in countries.
In Africa, the need for pharmacovigilance is increas-
ingly being recognized. In several countries of this conti-
nent, public health programs supported by WHO and
other partners have introduced pharmacovigilance for
antimalarial drugs in these countries. Though, this should
be expanded to safety monitoring of all drugs. Pharma-
covigilance requires substantial infrastructure, expertise
and funding, which are often lacking in African countries.
Objectives
To describe the current pharmacovigilance in African
countries and the contributing factors to its development,
Moroccan Pharmacovigilance Center as WHO collaborat-
ing center has conducted a study using a questionnaire
distributed to all African countries.To analyze data, coun-
tries were classified in groups.
Results
From this study, itappears that there is a good progress
in all African countries in the last decade with a differ-
ence between the North Africa and the sub-Saharan
Africa. Pharmacovigilance development is correlated
with the country development, the country language,
the health systems development, and the pharmaceutical
industry development.
The concept and principles of pharmacovigilance still
need time to be fully understood.
Conclusion
In this matter, leadership and dedicated personnel is
essential, advocacy and continuity are a sine qua non
condition for pharmacovigilance viability, minimum
established staff is needed, linkages with international
network are essential, need for pharmacovigilance to be
recognized by public health programs and regulators,
government and international support is needed and
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